搜尋結果
Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug Frenzy
Forbes· 11 小時前Danish pharma giant Novo Nordisk raised its 2024 outlook and beat profit expectations in its first-quarter earnings Thursday ...
Novartis to Buy Mariana Oncology, Paying $1 Billion Upfront
Bloomberg· 5 小時前Novartis agreed to buy US biotech Mariana Oncology Inc. in a deal to strengthen its pipeline of ...
Novo Trades at Hefty Discount to Lilly Even After 350% Rally
Bloomberg· 3 小時前... 350% rally over the past four years may have further to run if the weight-loss drug ... ...
Blockbuster obesity drug demand drives Novo Nordisk profit boost
Reuters· 6 小時前, opens new tab raised its 2024 outlook on Thursday and delivered better-than-expected ...
Can Ozempic Maker Novo Nordisk Keep Up Its Momentum? - What’s News - WSJ Podcasts
The Wall Street Journal· 6 小時前Emily Field: This morning, Novo talked about a quadrupling of new patients starting Wegovy on a weekly basis in the United ...
Wegovy, Mounjaro prices cut as British pharmacies compete for weight-loss patients
Reuters· 11 小時前Online pharmacies and slimming clinics are cutting prices for Wegovy and Mounjaro in Britain ...
Amgen investors await weight-loss drug data
Reuters· 1 日前, opens new tab investors eyeing dramatic share price gains for rivals with successful obesity ...
Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
Reuters· 1 日前... new patients suffering from type 2 diabetes began treatment with a reimbursed GLP-1 drug ...
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs
Reuters· 4 小時前, opens new tab raised its annual profit forecast on Thursday, betting on strength in its pharmaceutical unit selling costly ...
Repeated Reimbursement Haircuts From CMS Won’t Bend The Cost Curve
Forbes· 11 小時前In the fury of the healthcare debates over the last decade, most people have come to realize ...